Together, they demonstrate the clinical viability of the GLP-1/glucagon dual-agonist concept and suggest that this mechanism class will be a significant addition to the metabolic disease treatment landscape alongside tirzepatide and emerging triple agonists like retatrutide
Were here to guide you through this part of the journey: Nausea: Semaglutide and Tirzepatide can cause nausea, but it usually subsides over time
Additionally, it slows down the emptying of your stomach, further prolonging the sensation of fullness after meals
[...] Partnership for Safe Medicines releases action plan to protect patients from unapproved compounded GLP-1s PMSs new report outlines solutions to protect patient safety in the growing compounded GLP-1 marketplace
GLP-1 medications make it harder to eat full meals, so it becomes easier to miss key nutrients
Possible Triggers and Patterns Across user experiences, several possible patterns emerge